Search This Blog

Wednesday, August 5, 2020

bluebird bio EPS beats by $2.16, beats on revenue

bluebird bio (NASDAQ:BLUE): Q2 GAAP EPS of -$0.36 beats by $2.16.
Revenue of $198.89M (+1395.4% Y/Y) beats by $117.82M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)